Jun 16, 2026 07:32AM
May 26, 2026 08:25AM
May 26, 2026 08:25AM
May 19, 2026 06:00AM
May 19, 2026 06:00AM
May 18, 2026 08:42AM
May 18, 2026 08:42AM Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications
May 15, 2026 08:35AM
May 12, 2026 08:41AM
May 11, 2026 07:55AM
Apr 27, 2026 07:41AM
Apr 27, 2026 07:41AM
Apr 20, 2026 07:15AM
Apr 14, 2026 07:32AM Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Mar 13, 2026 07:46AM
Mar 13, 2026 07:45AM
Mar 11, 2026 09:07AM
Mar 4, 2026 07:30AM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:17AM
Dec 12, 2025 08:32AM Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
Dec 12, 2025 06:32AM
Dec 12, 2025 06:32AM
Dec 2, 2025 07:57AM
Nov 24, 2025 08:51AM
Nov 24, 2025 08:51AM
Nov 13, 2025 08:54AM
Nov 13, 2025 08:54AM Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
Nov 6, 2025 04:02PM
Nov 6, 2025 04:02PM
Oct 31, 2025 07:35AM
Jul 30, 2025 08:21AM
Jul 30, 2025 08:18AM
Apr 16, 2025 08:40AM
Apr 16, 2025 08:40AM Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
Apr 8, 2025 06:55AM
Mar 18, 2025 07:32AM
Mar 18, 2025 07:32AM
Jan 7, 2025 09:28AM
Jan 6, 2025 08:15AM
Jan 6, 2025 08:15AM
Aug 6, 2024 08:57AM Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug
Apr 17, 2024 07:49AM
Apr 17, 2024 07:49AM
Apr 10, 2024 07:17AM
Apr 10, 2024 07:17AM
Mar 19, 2024 07:55AM
Feb 23, 2024 07:06AM
Feb 23, 2024 07:06AM Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Feb 5, 2024 07:51AM

1,160,462 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All